Home - Annals of Pancreatic Cancer

Reviewer of the Month (2023)

In 2023, APC reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Annals of Pancreatic Cancer 2022 CiteScore Released: 1.6

We are pleased to announce that the Annals of Pancreatic Cancer (APC) has received its 2022 CiteScore: 1.6, ranking 98 out of 140 journals in the Internal Medicine category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

APC Annual Report 2021

Greetings from Editor-in-Chief and Editorial Office of Annals of Pancreatic Cancer!

We are pleased to share the 2021 Annual Report of Annals of Pancreatic Cancer here.

We would especially like to express our sincere gratitude to all supporters especially the editorial team members for all your support and contributions to Annals of Pancreatic Cancer from the inception of the journal. In 2022, we welcome more excellent international experts of the field to join and contribute to build APC a significant platform serving our scientists, doctors, patients and students in the field of pancreas. Wish you a happy, healthy and prosperous 2022!

Annals of Pancreatic Cancer (APC) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Annals of Pancreatic Cancer (APC) is among the list of COPE membership.

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

This manuscript describes the options in human models of pancreatic ductal adenocarcinoma and discusses how these models can be applied to translational research with an eye towards the clinical care of patients stricken with this disease.

MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer

The inversion recovery prepulse of T1-TFE increases contrast between normal and abnormal pancreatic tissue. Knowledge of imaging features and recognition of subtle changes in the pancreas could improve detection of early pancreatic cancer in a high-risk screening population.

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

T1C significantly increases in all phases of CE-MRI in responders to treatment, but does not change in non-responders. T1C correlates with treatment response, can be computed from clinical MRI exams, and may be useful as an additional metric to stratify patients undergoing treatment.

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020. Around 60 AME journals’ peer review systems are now integrated seamlessly into the Publons platform (https://publons.com/about/home). The partnership was done to recognize our expert peer reviewers spontaneously for their review contribution.

Why do we need a journal solely focused on the malignant diseases of the pancreas?

Pancreatic cancer has become the third leading cause of death from malignant diseases in both the United States and Europe. The incidence of pancreatic cancer is rising. Tremendous efforts have been devoted to basic and clinical research in pancreatic cancer. However, the outcome of pancreatic cancer has been minimally improved over the last thirty years. Such a profound sadness tells us that we should spend more efforts and be more focused on this disease. There had been no scientific journal that is solely focused on the malignant diseases of the pancreas. It is critical to have a media to rapidly disseminate research news and reports within the communities of pancreatic cancer researchers and have a venue to discuss the management strategies for pancreatic cancer among clinicians. This is why we are launching Annals of Pancreatic Cancer.

‹ ›

About apc

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: apc@amegroups.com
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Case Report

Pancreatic cancer with leptomeningeal carcinomatosis: case report and review of the literature

Michelle Seu, Adriana Sofia P. Perilla, Edward Melian, Michael J. Schneck

Annals of Pancreatic Cancer

2023;

(20 December 2023)

PDF Full Text (38) Peer Review File COI Form Open Access

Review Article 

Contribution of heterogeneity of cancer associated fibroblasts to organ-specific metastasis of pancreatic cancer: will it change the paradigm of treating metastatic pancreatic cancer?

Xiaonan Gong, Tengyi Zhang, Shu Zheng

Annals of Pancreatic Cancer

2023;

(20 November 2023)

PDF Full Text (53) COI Form Open Access

Original Article

Genetic alterations in the neuronal development genes are associated with changes of the tumor immune microenvironment in pancreatic cancer

Kaiyi Mu, Juan Fu, Jessica Gai, Harshitha Ravichandran, Lei Zheng, Wei-Chih Sun

Annals of Pancreatic Cancer

2023;

(20 November 2023)

PDF Full Text (80) Data Sharing Statement Peer Review File COI Form Open Access

Original Article

Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma—a single-center experience in India

Satyajeet Soni, Arpit Jain, Varun Goyal, Satya Narayan, Pallavi Redhu, Pankaj Goyal, Shiva Shankara Swamy, Vineet Talwar

Annals of Pancreatic Cancer

2023;

(15 November 2023)

PDF Full Text (48) Data Sharing Statement Peer Review File COI Form Open Access

Case Report

Painful tongue lesion as an initial presentation of metastatic pancreatic ductal adenocarcinoma: a case report and review of the literature

Cynthia Mark, Angela Minasyan, Matthew I. Ebia, Anser Abbas, Ankona Ghosh, Rabindra Watson, Horacio M. Maluf, Behrooz Hakimian, Brent Larson, Laura Elizabeth Mcvay, Jun Gong, Andrew Hendifar, Arsen Osipov

Annals of Pancreatic Cancer

2023;

(02 November 2023)

PDF Full Text (150) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Paraneoplastic Cushing syndrome caused by a pancreatic neuroendocrine tumor: a case report

Faten Cherchir, Sawsen Essayeh, Sabrine Mekni, Wafa Ben Hilel, Faten Gargouri, Karima Khiari, Ibtissam Ben Nacef, Imène Rojbi

Annals of Pancreatic Cancer

2023;

(30 October 2023)

PDF Full Text (115) Peer Review File COI Form Open Access

Original Article

Association of a genetic variant in the adenosine triphosphate transmembrane glycoprotein and risk of pancreatic cancer

Fatemeh Khojasteh-Leylakoohi, Ghazaleh Khalili-Tanha, Newsha Sardarzadeh, Nima Khalili-Tanha, Mohammad Dashtiahangar, Shima Mehrabadi, Alireza Asadnia, Amir Avan, Sakineh Amoueian, Seyed Mahdi Hassanian, Habibollah Esmaily, Majid Khazaei, Gordon A. Ferns, Mohsen Aliakbarian, Alireza Khooei

Annals of Pancreatic Cancer

2023;

(10 July 2023)

PDF Full Text (324) Data Sharing Statement Peer Review File COI Form Open Access

Original Article

Analysis of the receptor for advanced glycation end-products proteome and protein-protein interactome in PANC-1 cancer cells

Chaitanya Doshi, Nicholle M. Johnson, Charles A. Downs

Annals of Pancreatic Cancer

2023;

(15 June 2023)

PDF Full Text (399) Data Sharing Statement COI Form Open Access

Original Article

A prognostic machine learning model for the prediction of pancreatic adenocarcinoma prognosis based on genomic expression of four cell-cycle associated hub genes

Yaman B. Ahmed, Ayah N. Al-Bzour, Marwa T. Qaddoura, Maen Ahmed, Saif Aldeen Alryalat

Annals of Pancreatic Cancer

2023;

(20 April 2023)

PDF Full Text (462) Peer Review File COI Form Open Access

Mini-Review

Direct identification of T cell epitopes in cancer tissues

Yingkuan Shao, Tengyi Zhang, Betul Celiker, Kenji Fujiwara

Annals of Pancreatic Cancer

2023;

(20 April 2023)

PDF Full Text (439) COI Form Open Access

Case Report

Pancreatic metastasis of a primary osteosarcoma with genomic profiling analysis: case report and review of the literature

Roya P. Darioosh, Aatur Singhi, Mark E. Reeves, Wasseem Skef

Annals of Pancreatic Cancer

2023;

(28 February 2023)

PDF Full Text (926) Reporting Checklist COI Form Open Access

Mini-Review

The anti-metastasis effect of low-dose carbon monoxide

Binghe Wang, Yi-Chieh Nancy Du

Annals of Pancreatic Cancer

2023;

(08 February 2023)

PDF Full Text (704) COI Form Open Access

Original Article

Patients’ characteristics, diagnosis, and management of pancreatic masses in low resource settings

Nashivai Elias Kivuyo, Larry Onyango Akoko

Annals of Pancreatic Cancer

2022;

(30 December 2022)

PDF Full Text (619) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Editorial Commentary

Battling pancreatic cancer: the role of Chinese surgeons

Lei Zheng

Annals of Pancreatic Cancer

2022;

(31 October 2022)

PDF Full Text (658) COI Form Open Access

Mini-Review

A tumor intrinsic role of CD73 in pancreatic adenocarcinoma

Antao Chang, Jihui Hao

Annals of Pancreatic Cancer

2022;

(31 October 2022)

PDF Full Text (875) COI Form Open Access

Editorial Commentary

From pancreatic cancer to lung cancer, ZIP4’s oncogenic function continues

Shi-Yong Sun

Annals of Pancreatic Cancer

2022;

(30 July 2022)

PDF Full Text (519) COI Form Open Access

Editorial Commentary

“RHAMM knockout” mice express a truncated RHAMM protein that promotes pancreatic cancer progression with dysfunctional p53

Xiang Chen, Yi-Chieh Nancy Du

Annals of Pancreatic Cancer

2022;

(10 July 2022)

PDF Full Text (614) COI Form Open Access

Case Report

Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma—two case reports

Lawrence W. Wu, Syed M. Qasim Hussaini, Jae W. Lee, Daniel H. Shu, Ralph H. Hruban, Daniel A. Laheru

Annals of Pancreatic Cancer

2022;

(21 June 2022)

PDF Full Text (1178) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Pancreatic neuroendocrine tumor in a 27-year-old patient with Cornelia de Lange syndrome: a case report

Michael J. Wright, Antonie D. Kline, Christopher L. Wolfgang, Ammar A. Javed

Annals of Pancreatic Cancer

2022;

(30 May 2022)

PDF Full Text (711) Reporting Checklist COI Form Open Access

Original Article

EBF2 contributes to pancreatic cancer progenitor cell differentiation and tumor suppression

Hannah Mathew, Jennifer J. Barb, Soren Bentzen, Sheelu Varghese

Annals of Pancreatic Cancer

2022;

(10 April 2022)

PDF Full Text (1147) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

View more articles

Currently no content available!

Original Article

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin

Original Article

Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival

Alex B. Blair, Noelle R. Jurcak, Ammar Javed, Jonathan Teinor, Vincent P. Groot, Noah Rozich, John L. Cameron, Matthew J. Weiss, Jin He, Christopher L. Wolfgang, Lei Zheng, Richard A. Burkhart

Original Article

Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution

Alejandro Recio-Boiles, Jessica Vondrak, Summana Veeravelli, James J. Mancuso, Kathylynn Saboda, Denise J. Roe, Irbaz Bin Riaz, Aaron J. Scott, Emad Elquza, Ali McBride, Hani M. Babiker

Original Article

Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma

May Tun Saung, Lei Zheng

Original Article

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma

Alejandro Recio-Boiles, Aparna Nallagangula, Summana Veeravelli, Jessica Vondrak, Kathylynn Saboda, Denise Roe, Emad Elquza, Ali McBride, Hani M. Babiker

Review Article 

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions

Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart

Review Article 

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma

Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng

Review Article 

Targeting homologous recombination addicted tumors: challenges and opportunities

Talia Golan, Jonathan R. Brody

Review Article 

Evolving trends in pancreatic cancer therapeutic development

Imani Bijou, Jin Wang

Review Article 

Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors

Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du

Review Article 

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma

Yi Xu, Jun Liu, Michael Nipper, Pei Wang

Review Article 

Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon

Noah S. Rozich, Caitlin E. Jones, Katherine T. Morris

Review Article 

Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence

Adam R. Wolfe, Terence M. Williams

Review Article 

Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy

Sweet Ping Ng, Eugene J. Koay

Review Article 

Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma

Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour

Review Article 

Robotic distal pancreatectomy: greatest benefit for the frail?

Ioannis T. Konstantinidis, Laleh G. Melstrom

Editorial

Stressing for sugar: a new role of serotonin for glycolysis in pancreatic cancer cells

Gregory B. Lesinski

Editorial

Can computational modeling help in personalizing the care of patients with pancreatic ductal adenocarcinoma?

Efrat Dotan

Perspective 

Immune defects in pancreatic cancer

Lei Zheng

Journal Highlight more

Annals of Pancreatic Cancer is an international, open access, peer-reviewed journal for all researchers in the field of pancreatic cancer and for all health care providers who manage the care of pancreatic cancer patients, covering areas of basic biology and immunology, epidemiology, prevention, diagnosis, treatment, and supportive care.